Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care

Gold Standard/Elsevier Drug Information Improves Patient Education and Communication Between Health Providers and Patients Through new Partnership With Healthline Networks; Utilized by Yahoo.com

PHILADELPHIA, Pennsylvania, August 18, 2010 - The face of the medical consumer is changing. With the rapid
advance of Internet technology and the growing national focus on healthcare,
Americans are taking greater responsibility for their own medical care and
demanding the same health and medical information previously available only
to physicians and health officials. There are potential downsides to this
trend, however, as a recent study published in the American Journal of
Infection Control showed that over a four-month period in 2009, hundreds of
Twitter users posted casual misinformation about antibiotics — which, in
turn, reached more than a million followers.

Helping to provide quality, reliable drug information is Gold
Standard/Elsevier, a leading developer of drug information databases and
decision support solutions. Through a partnership with Healthline Networks,
Gold Standard drug information is reaching over 20 million health information
seekers on the Internet every month, including on Yahoo.com. Healthline, a
leading provider of web-based health information services, has developed
consumer-friendly health decision support applications, including Healthline
DrugSearch(TM) and Healthline TreatmentSearch(TM), which are built on and
integrate Gold Standard's data. These innovative tools allow users to
understand and compare treatments in the context of a specific condition to
better manage their health and wellness.

"In support of physicians and pharmacists who typically impart
medication information to patients, sophisticated drug databases such as
those powered by Gold Standard/Elsevier enable patients to become active
participants in their health and medical plans by providing trusted
information," said Marianne Messer, President, Gold Standard/Elsevier.
"Consumers can rely on information from credible providers, with accurate
content similar to that which is used by professionals."

"With the upcoming changes in the American healthcare system,
consumers must play more significant roles in their own medical care,
especially when it comes to prescription drugs," said West Shell, III,
Chairman and CEO, Healthline Networks. "With Healthline DrugSearch, built on
Gold Standard clinical data, consumers can understand all drug and treatment
options for a given condition and check for interactions, for example, if
they have prescriptions from multiple doctors. Healthline's decision support
tools have the sophistication and ease-of-use to deliver on the Gold Standard
belief that consumers need to take responsibility to know more about their
medications, which will help them build a better dialogue with their
physicians."

About Gold Standard/Elsevier (www.goldstandard.com)

Based in Tampa, FL, Gold Standard/Elsevier uses innovative
technologies to provide a complete suite of drug information and decision
support solutions. With a tenacious commitment to product quality, Gold
Standard/Elsevier solutions empower healthcare organizations, professionals
and consumers to meet the most pressing healthcare challenges, improve
patient safety and ensure optimal outcomes. To learn more about Gold
Standard/Elsevier, visit www.goldstandard.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is owned jointly by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Healthline

Healthline Networks (www.healthline.com/aboutus.jsp) is
a leading provider of intelligent health information services, enabling over
100 million consumers a month to make more confident, informed healthcare
decisions. The company's proprietary consumer healthcare taxonomy, the
largest of its kind, powers a suite of intelligent health search, content and
advertising services. Combining advanced search technology with deep medical
expertise, Healthline partners with a network of over 40 trusted destination
sites that include publishers, portals, search engines, employers and health
plans. Headquartered in San Francisco, Healthline is backed by Aetna,
GE/NBCU, Investor Growth Capital, Kaiser Permanente, Reed Elsevier, U.S. News
& World Report, and VantagePoint Venture Partners. For more information visit
www.healthline.com.

    Media Contact
    Tom Reller
    Vice President, Global Corporate Relations
    +1-215-239-3508
    T.Reller@Elsevier.com

Media Contact: Tom Reller, Vice President, Global Corporate Relations, +1-215-239-3508, T.Reller at Elsevier.com